For Immediate Release
Pleasanton, CA, October 8, 2012—To support its considerable investment in Europe and other local regions, CooperVision, Inc. announced a new president
“We are very excited to have someone with Mark’s experience and accomplishments joining the CooperVision team and leading our European efforts,” said Dennis Murphy, Executive Vice President of Global Sales and Marketing for CooperVision
Mark will begin his new role effective October 8, 2012 and work from the CooperVision Delta Park offices located in the United Kingdom.
CooperVision, a unit of The Cooper Companies, Inc. (NYSE:COO), is one of the world's leading manufacturers of soft contact lenses. Dedicated to continually bringing a refreshing perspective to the contact lens experience for practitioners and patients, CooperVision specializes in lenses for astigmatism, presbyopia, and ocular dryness. The company routinely collaborates with eye care professionals in the research and development of relevant products. CooperVision manufactures a full array of monthly, two-week, and daily disposable contact lenses featuring advanced materials and optics. For more information, visit www.coopervision.com.
About The Cooper Companies
The Cooper Companies, Inc. (“Cooper”) is a global medical device company publicly traded on the NYSE Euronext (NYSE:COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to crafting a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical focuses on supplying women’s health clinicians with market leading products and treatment options to improve the delivery of healthcare to women. Headquartered in Pleasanton, CA, Cooper has over 7,500 employees with products sold in over 100 countries. For more information, please visit www.coopercos.com.